Medical Weight Loss

Medical weight loss at Optimize 360 goes beyond diet pills and willpower. We combine FDA-backed GLP-1 medications — semaglutide, tirzepatide, and retatrutide — with comprehensive hormone optimization to address the metabolic root causes of stubborn weight gain.

Why Traditional Diets Fail

The failure rate of traditional diets is 95% — not because people lack discipline, but because dieting triggers adaptive mechanisms that fight weight loss: metabolic rate decreases, hunger hormones increase, and the body prioritizes fat storage. Add hormonal imbalances — low testosterone, elevated insulin, thyroid dysfunction, high cortisol — and you have a metabolic environment that makes sustained weight loss nearly impossible through behavior change alone. Medical weight loss addresses the biology, not just the behavior.

The Three GLP-1 Options Explained

Semaglutide is the most established GLP-1 agonist for weight loss. It reduces appetite, slows gastric emptying, and improves insulin sensitivity. Average weight loss: 15-20% of body weight over 68 weeks. It's our most commonly prescribed starting medication.

Tirzepatide is a dual GIP/GLP-1 agonist that outperformed semaglutide in head-to-head trials. Average weight loss: 20-25% of body weight. We recommend it for patients who want maximum results or have plateaued on semaglutide.

Retatrutide is a triple agonist (GIP/GLP-1/glucagon) currently in late-stage clinical trials showing up to 24% body weight loss in Phase 2 data. It represents the next frontier in metabolic therapy.

The Hormone Connection Most Clinics Miss

Here's what most weight loss clinics don't tell you: GLP-1 medications alone don't fix the underlying hormonal dysfunction that caused the weight gain. Low testosterone drives fat accumulation and muscle loss. Thyroid dysfunction slows metabolism. Insulin resistance makes every calorie more likely to be stored as fat. Elevated cortisol promotes visceral fat storage. At Optimize 360, we test all of these markers and address them alongside your GLP-1 therapy. The result: faster fat loss, better muscle preservation, more energy, and — critically — results that last after you taper off the medication.

What to Expect Month by Month

Month 1: Appetite reduction is immediate — most patients notice within the first week. Cravings diminish. Initial weight loss of 3-5% body weight is common. Some patients experience mild nausea during dose titration, which typically resolves within 2-3 weeks.

Months 2-3: Weight loss accelerates. Clothing fits noticeably different. Energy improves as metabolic function optimizes. Lab markers begin improving — lower fasting insulin, better A1C, reduced inflammation. Exercise feels more productive.

Months 3-6: This is where the compounding effect of GLP-1 + hormone optimization becomes dramatic. 10-15%+ body weight loss. Bloodwork markers improve significantly. Body composition shifts visibly — less fat, more preserved muscle. Patients consistently report this is when they "feel like a different person."

Months 6-12: Approaching goal weight. With hormones optimized, metabolic rate is preserved (unlike crash diets where metabolism tanks). We begin discussing long-term strategy — maintenance dosing, lifestyle habits, and when/how to taper.

Medical Weight Loss vs Commercial Programs

Commercial weight loss programs (Weight Watchers, Noom, Optavia, etc.) rely on behavioral change and caloric restriction. They work for some people in the short term, but the 5-year success rate is approximately 5%. The reason: they don't address the biological drivers of weight gain. Hormonal imbalance, insulin resistance, and metabolic adaptation make it physiologically impossible for many people to lose weight through behavior change alone. Medical weight loss at Optimize 360 addresses the biology first — using GLP-1 medications to manage appetite/insulin and hormone optimization to fix the underlying metabolic dysfunction — then supports with behavioral guidance. Biology first, behavior second.

Insurance, Pricing, and the Direct-Pay Advantage

Branded GLP-1 medications (Ozempic, Wegovy, Mounjaro, Zepbound) cost $1,000-1,500/month without insurance, and insurance coverage is inconsistent, requiring prior authorizations, step therapy, and frequent denials. We use compounded semaglutide and tirzepatide from licensed U.S. pharmacies at a fraction of the branded cost. Our direct-pay model means no insurance hassle, no prior authorizations, no coverage gaps, and no surprise bills. You know exactly what you'll pay before you start. Contact us for current pricing.

When to Consider Medical Weight Loss

Consider medical weight loss if: you've tried multiple diets without lasting results, you have a BMI of 27+ with health conditions or 30+, your weight is affecting your quality of life (energy, mood, self-confidence, relationships, health), you suspect hormonal imbalance is contributing to weight gain, or you're pre-diabetic or insulin resistant. You don't need to have "tried everything" first — waiting until you've exhausted every other option means years of metabolic damage that makes treatment harder. Starting sooner produces better, faster, and more durable results.

Related Resources